The Latin America, Middle East and Africa Uveitis Treatment Market would witness market growth of 6.5% CAGR during the forecast period (2019-2025). For the treatment of infectious uveitis, certain medications have advantages over others. Topical and systemic treatments are often used in the treatment of ocular infection, but the treatment route may be limited by penetration, concentration, and duration. The advent of antimicrobial intravitreal therapy has furthered the treatment of intraocular infections. With limited systemic absorption, being able to overcome blood-ocular barriers allows for large concentrations of drugs to be administered directly to the posterior section. Nevertheless, because the difference between the therapeutic and toxic doses of certain antimicrobial drugs falls within a small range of concentration, intravitreal therapy can be associated with risks of ocular toxicity.
Intermediate uveitis is a vitreous and peripheral retina-localized type of uveitis. Primary inflammatory sites include the vitreous which includes other entities such as pars planitis, posterior cyclitis, and hyalitis. Intermediate uveitis may be either an isolated eye disease or related to the development of a systemic condition such as multiple sclerosis or sarcoidosis. As such, the first manifestation of a systemic disorder may be intermediate uveitis. Infectious causes of intermediate uveitis include infection with the Epstein-Barr virus, Lyme disease, HTLV-1 virus, cat scratch disease, and hepatitis C.
Permanent vision loss is most often observed in patients suffering from chronic cystoid macular edema (CME). While present, every attempt must be made to eliminate CME. Retinal detachment, glaucoma, band keratopathy, cataract, vitreous hemorrhage, epiretinal membrane, and choroidal neovascularization are also less common causes of visual impairment.
Based on Drug Class, the market is segmented into Anti-inflammatory, Immunotherapy & Targeted Therapies, Antimicrobial Drugs and Other Drug Class. Based on Disease Type, the market is segmented into Anterior Uveitis, Posterior Uveitis, Intermediate Uveitis and Panuveitis. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies and Online stores. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: Uveitis Treatment Market in LAMEA is expected to register a CAGR of 6.5% during the forecast period (2019-2025)
The market research report covers theanalysis of key stake holders of the market. Key companies profiled in the report include AbbVie, Inc., Alimera Sciences, Inc., Enzo Biochem, Inc., Amgen, Inc., Bausch Health Companies, Inc., Clearside Biomedical, Inc., EyePoint Pharmaceuticals, Inc., Santen Pharmaceutical Co., Ltd., TopiVert Ltd., and Novartis AG.
Scope of the LAMEA Uveitis Treatment Market Analysis
Market Segmentation:
By Drug Class
- Anti-inflammatory
- Immunotherapy & Targeted Therapies
- Antimicrobial Drugs
- Other Drug Class
By Disease Type
- Anterior Uveitis
- Posterior Uveitis
- Intermediate Uveitis
- Panuveitis
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online stores
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Companies Profiled
- AbbVie, Inc.
- Alimera Sciences, Inc.
- Enzo Biochem, Inc.
- Amgen, Inc.
- Bausch Health Companies, Inc.
- Clearside Biomedical, Inc.
- EyePoint Pharmaceuticals, Inc.
- Santen Pharmaceutical Co., Ltd.
- TopiVert Ltd.
- Novartis AG
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Uveitis Treatment Market, by Drug Class
1.4.2 LAMEA Uveitis Treatment Market, by Disease Type
1.4.3 LAMEA Uveitis Treatment Market, by Distribution Channel
1.4.4 LAMEA Uveitis Treatment Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. LAMEA Uveitis Treatment Market by Drug Class
3.1 LAMEA Anti-inflammatory Market by Country
3.2 LAMEA Immunotherapy & Targeted Therapies Market by Country
3.3 LAMEA Antimicrobial Drugs Market by Country
3.4 LAMEA Other Drug Class Market by Country
Chapter 4. LAMEA Uveitis Treatment Market by Disease Type
4.1 LAMEA Anterior Uveitis Market by Country
4.2 LAMEA Posterior Uveitis Market by Country
4.3 LAMEA Intermediate Uveitis Market by Country
4.4 LAMEA Other Diseases Market by Country
Chapter 5. LAMEA Uveitis Treatment Market by Distribution Channel
5.1 LAMEA Hospital Pharmacies Market by Country
5.2 LAMEA Retail Pharmacies Market by Country
5.3 LAMEA Online stores Market by Country
Chapter 6. LAMEA Uveitis Treatment Market by Country
6.1 Brazil Uveitis Treatment Market
6.1.1 Brazil Uveitis Treatment Market by Drug Class
6.1.2 Brazil Uveitis Treatment Market by Disease Type
6.1.3 Brazil Uveitis Treatment Market by Distribution Channel
6.2 Argentina Uveitis Treatment Market
6.2.1 Argentina Uveitis Treatment Market by Drug Class
6.2.2 Argentina Uveitis Treatment Market by Disease Type
6.2.3 Argentina Uveitis Treatment Market by Distribution Channel
6.3 UAE Uveitis Treatment Market
6.3.1 UAE Uveitis Treatment Market by Drug Class
6.3.2 UAE Uveitis Treatment Market by Disease Type
6.3.3 UAE Uveitis Treatment Market by Distribution Channel
6.4 Saudi Arabia Uveitis Treatment Market
6.4.1 Saudi Arabia Uveitis Treatment Market by Drug Class
6.4.2 Saudi Arabia Uveitis Treatment Market by Disease Type
6.4.3 Saudi Arabia Uveitis Treatment Market by Distribution Channel
6.5 South Africa Uveitis Treatment Market
6.5.1 South Africa Uveitis Treatment Market by Drug Class
6.5.2 South Africa Uveitis Treatment Market by Disease Type
6.5.3 South Africa Uveitis Treatment Market by Distribution Channel
6.6 Nigeria Uveitis Treatment Market
6.6.1 Nigeria Uveitis Treatment Market by Drug Class
6.6.2 Nigeria Uveitis Treatment Market by Disease Type
6.6.3 Nigeria Uveitis Treatment Market by Distribution Channel
6.7 Rest of LAMEA Uveitis Treatment Market
6.7.1 Rest of LAMEA Uveitis Treatment Market by Drug Class
6.7.2 Rest of LAMEA Uveitis Treatment Market by Disease Type
6.7.3 Rest of LAMEA Uveitis Treatment Market by Distribution Channel
Chapter 7. Company Profiles
7.1 AbbVie, Inc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 Recent strategies and developments:
7.1.5.1 Approvals:
7.2 Alimera Sciences, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expense
7.2.1 Recent strategies and developments:
7.2.1.1 Product Launches and Product Expansions:
7.3 Enzo Biochem, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.4 Amgen, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Research & Development Expense
7.4.4 Recent strategies and developments:
7.4.4.1 Product Launches and Product Expansions:
7.4.4.2 Partnerships, Collaborations, and Agreements:
7.5 Bausch Health Companies, Inc.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Partnerships, Collaborations, and Agreements:
7.6 Clearside Biomedical, Inc.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Research & Development Expense
7.6.4 Recent strategies and developments:
7.6.4.1 Partnerships, Collaborations, and Agreements:
7.7 EyePoint Pharmaceuticals, Inc.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expense
7.7.5 Recent strategies and developments:
7.7.5.1 Product Launches and Product Expansions:
7.7.5.2 Acquisition and Mergers:
7.8 Santen Pharmaceutical Co., Ltd.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Regional Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Partnerships, Collaborations, and Agreements:
7.9 Topivert Ltd.
7.9.1 Company Overview
7.1 Novartis AG
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Recent strategies and developments:
7.10.4.1 Acquisition and Mergers:
7.10.4.2 Approvals:
7.10.5 Research & Development Expense
TABLE 1 LAMEA Uveitis Treatment Market, 2015 - 2018, USD Million
TABLE 2 LAMEA Uveitis Treatment Market, 2019 - 2025, USD Million
TABLE 3 LAMEA Uveitis Treatment Market by Drug Class, 2015 - 2018, USD Million
TABLE 4 LAMEA Uveitis Treatment Market by Drug Class, 2019 - 2025, USD Million
TABLE 5 LAMEA Anti-inflammatory Market by Country, 2015 - 2018, USD Million
TABLE 6 LAMEA Anti-inflammatory Market by Country, 2019 - 2025, USD Million
TABLE 7 LAMEA Immunotherapy & Targeted Therapies Market by Country, 2015 - 2018, USD Million
TABLE 8 LAMEA Immunotherapy & Targeted Therapies Market by Country, 2019 - 2025, USD Million
TABLE 9 LAMEA Antimicrobial Drugs Market by Country, 2015 - 2018, USD Million
TABLE 10 LAMEA Antimicrobial Drugs Market by Country, 2019 - 2025, USD Million
TABLE 11 LAMEA Other Drug Class Market by Country, 2015 - 2018, USD Million
TABLE 12 LAMEA Other Drug Class Market by Country, 2019 - 2025, USD Million
TABLE 13 LAMEA Uveitis Treatment Market by Disease Type, 2015 - 2018, USD Million
TABLE 14 LAMEA Uveitis Treatment Market by Disease Type, 2019 - 2025, USD Million
TABLE 15 LAMEA Anterior Uveitis Market by Country, 2015 - 2018, USD Million
TABLE 16 LAMEA Anterior Uveitis Market by Country, 2019 - 2025, USD Million
TABLE 17 LAMEA Posterior Uveitis Market by Country, 2015 - 2018, USD Million
TABLE 18 LAMEA Posterior Uveitis Market by Country, 2019 - 2025, USD Million
TABLE 19 LAMEA Intermediate Uveitis Market by Country, 2015 - 2018, USD Million
TABLE 20 LAMEA Intermediate Uveitis Market by Country, 2019 - 2025, USD Million
TABLE 21 LAMEA Other Diseases Market by Country, 2015 - 2018, USD Million
TABLE 22 LAMEA Other Diseases Market by Country, 2019 - 2025, USD Million
TABLE 23 LAMEA Uveitis Treatment Market by Distribution Channel, 2015 - 2018, USD Million
TABLE 24 LAMEA Uveitis Treatment Market by Distribution Channel, 2019 - 2025, USD Million
TABLE 25 LAMEA Hospital Pharmacies Market by Country, 2015 - 2018, USD Million
TABLE 26 LAMEA Hospital Pharmacies Market by Country, 2019 - 2025, USD Million
TABLE 27 LAMEA Retail Pharmacies Market by Country, 2015 - 2018, USD Million
TABLE 28 LAMEA Retail Pharmacies Market by Country, 2019 - 2025, USD Million
TABLE 29 LAMEA Online stores Market by Country, 2015 - 2018, USD Million
TABLE 30 LAMEA Online stores Market by Country, 2019 - 2025, USD Million
TABLE 31 LAMEA Uveitis Treatment Market by Country, 2015 - 2018, USD Million
TABLE 32 LAMEA Uveitis Treatment Market by Country, 2019 - 2025, USD Million
TABLE 33 Brazil Uveitis Treatment Market, 2015 - 2018, USD Million
TABLE 34 Brazil Uveitis Treatment Market, 2019 - 2025, USD Million
TABLE 35 Brazil Uveitis Treatment Market by Drug Class, 2015 - 2018, USD Million
TABLE 36 Brazil Uveitis Treatment Market by Drug Class, 2019 - 2025, USD Million
TABLE 37 Brazil Uveitis Treatment Market by Disease Type, 2015 - 2018, USD Million
TABLE 38 Brazil Uveitis Treatment Market by Disease Type, 2019 - 2025, USD Million
TABLE 39 Brazil Uveitis Treatment Market by Distribution Channel, 2015 - 2018, USD Million
TABLE 40 Brazil Uveitis Treatment Market by Distribution Channel, 2019 - 2025, USD Million
TABLE 41 Argentina Uveitis Treatment Market, 2015 - 2018, USD Million
TABLE 42 Argentina Uveitis Treatment Market, 2019 - 2025, USD Million
TABLE 43 Argentina Uveitis Treatment Market by Drug Class, 2015 - 2018, USD Million
TABLE 44 Argentina Uveitis Treatment Market by Drug Class, 2019 - 2025, USD Million
TABLE 45 Argentina Uveitis Treatment Market by Disease Type, 2015 - 2018, USD Million
TABLE 46 Argentina Uveitis Treatment Market by Disease Type, 2019 - 2025, USD Million
TABLE 47 Argentina Uveitis Treatment Market by Distribution Channel, 2015 - 2018, USD Million
TABLE 48 Argentina Uveitis Treatment Market by Distribution Channel, 2019 - 2025, USD Million
TABLE 49 UAE Uveitis Treatment Market, 2015 - 2018, USD Million
TABLE 50 UAE Uveitis Treatment Market, 2019 - 2025, USD Million
TABLE 51 UAE Uveitis Treatment Market by Drug Class, 2015 - 2018, USD Million
TABLE 52 UAE Uveitis Treatment Market by Drug Class, 2019 - 2025, USD Million
TABLE 53 UAE Uveitis Treatment Market by Disease Type, 2015 - 2018, USD Million
TABLE 54 UAE Uveitis Treatment Market by Disease Type, 2019 - 2025, USD Million
TABLE 55 UAE Uveitis Treatment Market by Distribution Channel, 2015 - 2018, USD Million
TABLE 56 UAE Uveitis Treatment Market by Distribution Channel, 2019 - 2025, USD Million
TABLE 57 Saudi Arabia Uveitis Treatment Market, 2015 - 2018, USD Million
TABLE 58 Saudi Arabia Uveitis Treatment Market, 2019 - 2025, USD Million
TABLE 59 Saudi Arabia Uveitis Treatment Market by Drug Class, 2015 - 2018, USD Million
TABLE 60 Saudi Arabia Uveitis Treatment Market by Drug Class, 2019 - 2025, USD Million
TABLE 61 Saudi Arabia Uveitis Treatment Market by Disease Type, 2015 - 2018, USD Million
TABLE 62 Saudi Arabia Uveitis Treatment Market by Disease Type, 2019 - 2025, USD Million
TABLE 63 Saudi Arabia Uveitis Treatment Market by Distribution Channel, 2015 - 2018, USD Million
TABLE 64 Saudi Arabia Uveitis Treatment Market by Distribution Channel, 2019 - 2025, USD Million
TABLE 65 South Africa Uveitis Treatment Market, 2015 - 2018, USD Million
TABLE 66 South Africa Uveitis Treatment Market, 2019 - 2025, USD Million
TABLE 67 South Africa Uveitis Treatment Market by Drug Class, 2015 - 2018, USD Million
TABLE 68 South Africa Uveitis Treatment Market by Drug Class, 2019 - 2025, USD Million
TABLE 69 South Africa Uveitis Treatment Market by Disease Type, 2015 - 2018, USD Million
TABLE 70 South Africa Uveitis Treatment Market by Disease Type, 2019 - 2025, USD Million
TABLE 71 South Africa Uveitis Treatment Market by Distribution Channel, 2015 - 2018, USD Million
TABLE 72 South Africa Uveitis Treatment Market by Distribution Channel, 2019 - 2025, USD Million
TABLE 73 Nigeria Uveitis Treatment Market, 2015 - 2018, USD Million
TABLE 74 Nigeria Uveitis Treatment Market, 2019 - 2025, USD Million
TABLE 75 Nigeria Uveitis Treatment Market by Drug Class, 2015 - 2018, USD Million
TABLE 76 Nigeria Uveitis Treatment Market by Drug Class, 2019 - 2025, USD Million
TABLE 77 Nigeria Uveitis Treatment Market by Disease Type, 2015 - 2018, USD Million
TABLE 78 Nigeria Uveitis Treatment Market by Disease Type, 2019 - 2025, USD Million
TABLE 79 Nigeria Uveitis Treatment Market by Distribution Channel, 2015 - 2018, USD Million
TABLE 80 Nigeria Uveitis Treatment Market by Distribution Channel, 2019 - 2025, USD Million
TABLE 81 Rest of LAMEA Uveitis Treatment Market, 2015 - 2018, USD Million
TABLE 82 Rest of LAMEA Uveitis Treatment Market, 2019 - 2025, USD Million
TABLE 83 Rest of LAMEA Uveitis Treatment Market by Drug Class, 2015 - 2018, USD Million
TABLE 84 Rest of LAMEA Uveitis Treatment Market by Drug Class, 2019 - 2025, USD Million
TABLE 85 Rest of LAMEA Uveitis Treatment Market by Disease Type, 2015 - 2018, USD Million
TABLE 86 Rest of LAMEA Uveitis Treatment Market by Disease Type, 2019 - 2025, USD Million
TABLE 87 Rest of LAMEA Uveitis Treatment Market by Distribution Channel, 2015 - 2018, USD Million
TABLE 88 Rest of LAMEA Uveitis Treatment Market by Distribution Channel, 2019 - 2025, USD Million
TABLE 89 Key information – AbbVie, Inc.
TABLE 90 Key Information – Alimera Sciences, Inc.
TABLE 91 key information – Enzo Biochem, Inc.
TABLE 92 Key Information – Amgen, Inc.
TABLE 93 key information – Bausch Health Companies, Inc.
TABLE 94 Key Information – Clearside Biomedical, Inc.
TABLE 95 Key Information – EyePoint Pharmaceuticals, Inc.
TABLE 96 Key Information – Santen Pharmaceutical Co., Ltd.
TABLE 97 Key Information – Topivert Ltd.
Table 98 Key Information – Novartis AG
List of Figures
FIG 1 Methodology for the research